Evidence map›Paper›PMID 22013071›Full record

ArticleThe Journal of biological chemistry2011

Characterization of the Src/Abl hybrid kinase SmTK6 of Schistosoma mansoni.

Svenja Beckmann, Steffen Hahnel, Katia Cailliau, Mathieu Vanderstraete, Edith Browaeys, Colette Dissous, Christoph G Grevelding

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Targeting Kinases inFrontiers in veterinary science · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Imatinib activity on Schistosoma mansoni.Memorias do Instituto Oswaldo Cruz · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Svenja BeckmannInstitute for Parasitology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Steffen HahnelInstitute for Parasitology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Katia CailliauEA 4479, IFR 147, Universite Lille 1 Sciences et Technologies, 59655 Villeneuve d'Ascq Cedex, France.
Mathieu VanderstraeteCenter for Infection and Immunity of Lille, Inserm U1019, CNRS-UMR 8204, Institut Pasteur Lille, 59019 Lille, France.
Edith BrowaeysEA 4479, IFR 147, Universite Lille 1 Sciences et Technologies, 59655 Villeneuve d'Ascq Cedex, France.
Colette DissousCenter for Infection and Immunity of Lille, Inserm U1019, CNRS-UMR 8204, Institut Pasteur Lille, 59019 Lille, France.
Christoph G GreveldingInstitute for Parasitology, Justus-Liebig-University Giessen, 35392 Giessen, Germany. Electronic address: Christoph.Grevelding@vetmed.uni-giessen.de.
University of Giessen · DEUniversité de Lille · FRInstitut Pasteur · FRInstitut Pasteur de Lille · FR

Funding

Wellcome Trust
6 · The paper itself

Abstract

Cellular protein-tyrosine kinases play key roles in signal transduction processes in eukaryotes. SmTK4 was the first Syk kinase identified in a parasite and found to be tissue-specifically transcribed in the gonads of adult Schistosoma mansoni. Functional analyses confirmed its role in oogenesis and spermatogenesis. As an SmTK4 upstream binding partner, the cellular protein-tyrosine kinase SmTK6 was isolated from a yeast two-hybrid library. Phylogenetic analyses performed in this study confirmed the first suggestions of a hybrid character of SmTK6. Biochemical studies made in Xenopus oocytes using inhibitors against Src (herbimycin A) and Abl (imatinib) kinases exhibited a biochemical inhibition profile of SmTK6, which was intermediate of Src and Abl kinases. As SmTK6 upstream interaction partners, we identified among others the known Src kinase SmTK3 and the Venus kinase receptor SmVKR1 of S. mansoni by yeast two-hybrid analyses, all of which co-localized in the gonads. Co-immunoprecipitation experiments confirmed interactions between SmTK6 and SmTK3 or SmVKR1. In Xenopus oocytes, it was finally shown that SmVKR1 but also SmTK3 were able to activate SmTK6 enzymatic activity indicating its functions in a receptor tyrosine kinase signal transduction cascade. These results not only demonstrate an intermediate but Src-biased profile of the unusual kinase SmTK6. They also strongly substantiate previous indications for a kinase complex, consisting of a receptor tyrosine kinase, Syk and Src kinases, which has been hypothesized to be involved in proliferation and differentiation processes in the gonads of schistosomes.

Indexed as

AnimalsBenzamidesBenzoquinonesCell DifferentiationCell ProliferationCSK Tyrosine-Protein KinaseHumansImatinib MesylateLactams, MacrocyclicOocytesPhylogenyPiperazinesProtein BindingProtein-Tyrosine KinasesProto-Oncogene Proteins c-ablPyrimidinesBenzamidesBenzoquinonesCSK protein, humanCSK Tyrosine-Protein KinaseherbimycinImatinib MesylateLactams, MacrocyclicPiperazinesProtein-Tyrosine KinasesProto-Oncogene Proteins c-ablPyrimidinesRifabutinsrc-Family Kinases

Identifiers

PMID22013071
PMCPMC3234968
OpenAlexW2153714061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.